|
Related Articles |
A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms.
J Clin Psychopharmacol. 2013 Dec;33(6):824-7
Authors: van der Meer JM, Harfterkamp M, van de Loo-Neus G, Althaus M, de Ruiter SW, Donders AR, de Sonneville LM, Buitelaar JK, Hoekstra PJ, Rommelse NN
PMID: 24018545 [PubMed – indexed for MEDLINE]

